T69231
Dinapsoline
TargetMol
DESCRIPTION
Dinapsoline is a drug developed for the treatment of Parkinson's disease, that acts as a selective full agonist at the dopamine D1 receptor.
DETAILS
- Cas: 458563-40-1
- Purity: 98%
- Category: Compound
- Molecular Weight: 253.301
- Molecular Formula: C16H15NO2
Lead Time: 4 - 5 weeks
Sign in to view pricing